(March 27, 2018, 1:58 PM EDT) -- HARTFORD, Conn. — A Connecticut state court jury on March 23 said Boehringer Ingelheim Pharmaceuticals Inc. failed to provide an adequate warning that its Pradaxa anticoagulant could cause uncontrolled internal bleeding but also ruled that a daughter representing her mother’s estate failed to prove that the defendant’s wrongful conduct was the legal cause of the mother’s injury (Geralynn Boone, et al. v. Boehringer Ingelheim Pharmaceuticals, Inc., et al., No. X03-HHD-CV16-6067796-S, Conn. Super., Hartford Co.)....